维普期刊资源整合服务平台（V6.5）

36篇 您的检索式：作者名="Katzeff"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Efficacy and safety of monotherapy of Sitagliptin compared with metformin in patients with type 2 diabetes显示文摘	Aschner P Katzeff HL Guo H	2010	Diabetes Obes Metab2010，12，3：	1
2	Sitagliptin, a DPP-d inhibitor for the treatment of patients with type 2 diabetes : a review of recent clinical trials 显示文摘	Avraham Karasik Pablo Aschner harvey Katzeff	2008	Curr Med Res Opin2008，24，2：	1
3	Efficacy and safety of monotherapy of sitagliptin compared with metformin inpa- tients with type 2 diabetes显示文摘	Aschner P Katzeff HL Guo H et a/	2010	Diabetes Obes Metab2010，12，1：	1
4	Efficacy and safety of monotherapy of sitagliplin compared with metformin in palients with type 2 diabetes显示文摘	Aschner P Katzeff HL Guo H	2010	Diabetes Obes Metab2010，12，：	1
5	System demands on mental models for a fulltext database 显示文摘	Katzeff C	1990	International Journal of Man-Machine Studies1990，32，5：	1
6	Efficacy and safe-ty of monotherapy of sitagliptin compared with metformin in pa-tients with type 2 diabetes 显示文摘	ASCHNER P KATZEFF H L CDO H	2010	Diabetes Obes Metab2010，12，3：	1
7	Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes显示文摘	Aschner P Katzeff HL Guo H	2010	Diabetes Obes Metab2010，12，3：	1
8	System demands on mental models for a fulltext database显示文摘	Katzeff C		0，，32：	1
9	Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2diabetes显示文摘	Aschner P Katzeff HL Guo H	2012	Diabete Obes Metab2012，12，1：	1
10	Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes 显示文摘	Aschner P Katzeff HL Guo H	2010	Diabetes Obes Metab2010，12，：	1
11	Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes显示文摘	Aschner P Katzeff HL Guo H	2010	Diabetes Obes Metab2010，12，3：	1
12	Efficacy and safety of monothe- rapy of sitagliptin compared with metformin in patients with type 2 dia-betes 显示文摘	Aschner P Katzeff HL Guo H	2010	Diabetes Obes Metab2010，12，3：	1
13	Sick euthyroid syndrome is associated with decreased TR expression in mouse liver 显示文摘	Katzeff HL	1997	Clin Metab1997，36，：	1
14	Sitagliptin,a DPP-4Inhibitor for the Treatment of Patients with Type 2 Diabetes:a Review of Recent Clinical Trials显示文摘	KARASIK A ASCHNER P KATZEFF H	2008	Curr Med Res Opin2008，24，2：	1
15	Efficacy and safety of monotherapy of Sitagliptin compared with mefformin in patients with type 2 diabetes 显示文摘	Aschner P Katzeff HL Guo H	2010	Diabetes Obes Metab2010，12，3：	1
16	Sitagliptin, a DPP - 4 inhibitor for the treatment of patients with type 2 diabetes: a review ofrecent clinical trials显示文摘	Karasik A Aschner P Katzeff H	2008	Curr Med Res Opin2008，24，2：	1
17	Euthyroid Sick syrdrome显示文摘	Dillmann WH Wenkerl M et al	1997	J clin Endocrinol Metab1997，36，：	1
18	Alterations in cardiac contractility and gene expression during low-T3 syndrome:prevention with T3显示文摘	Katzeff HL Powell SR Ojamaa K	1997	Am J Physiol Endocrinol Metab1997，273，51：	1
19	Efficacy and safety of mono-therapy of sitagliptin compared with metformin in patients with type 2diabetes显示文摘	Aschner P Katzeff Hl Guo H	2010	Diabetes Obes Metab2010，12，3：	1
20	Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type2 diabetes显示文摘	Aschner P Katzeff HL Guo H Sitagliptin Study 049 Group	2010	Diabetes Obes Metab2010，12，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示